Phase II study of docetaxel (TXT) and carboplatin (CBDCA) combination in advanced non-small cell lung cancer (NSCLC). An ongoing study

✍ Scribed by Giannakakis, T; Kakolyris, S; Papadouris, S; Theodoropoulos, I; Kalbakis, K; Androulakis, N; Souglakos, J; Agelaki, S; Malliotakis, P; Georgoulias, V

• Book ID: 118569745
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 114 KB
• Volume: 29
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(00)80200-7